Amgen To Discuss Details Of Repatha™ (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Amgen To Discuss Details Of Repatha™ (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol
Amgen Inc (NASDAQ: AMGN) Delayed: 344.72 +7.12 (2.11%)
Previous Close $337.60    52 Week High $176.85 
Open $337.65    52 Week Low $133.64 
Day High $345.11    P/E 51.92 
Day Low $337.60    EPS $6.64 
Volume 2,520,731